Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Market Cap	10.83B
Revenue (ttm)	2.41B
Net Income (ttm)	417.95M
Shares Out	206.30M
EPS (ttm)	2.00
PE Ratio	26.26
Forward PE	21.62
Dividend	1.27 (2.40%)
Ex-Dividend Date	May 19, 2025

Volume	82,810
Average Volume	398,557
Open	53.00
Previous Close	52.50
Day's Range	52.45 - 53.15
52-Week Range	43.98 - 60.95
Beta	0.53
RSI	58.89
Earnings Date	May 8, 2025

About BIT:REC

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops REC 0545 for acute decompensation in maple syrup urine diseases; Isturia for endogenous Cushing’s syndrome; Cystadrops for corneal cystine crystal deposits; Carbaglu for hyperammonemia due ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1926
• Employees: 4,583
• Stock Exchange: Borsa Italiana
• Ticker Symbol: REC

Financial Performance

In 2024, BIT:REC's revenue was 2.34 billion, an increase of 12.45% compared to the previous year's 2.08 billion. Earnings were 416.51 million, an increase of 7.01%.